|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| C07K 16/22 | |||
| A61K 39/395 | |||
| A61P 13/08 | |||
| A61P 13/10 |
| (11) | Number of the document | 2291403 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09762162.7 |
| Date of filing the European patent application | 2009-06-15 | |
| (97) | Date of publication of the European application | 2011-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2009/052535 |
| Date | 2009-06-15 |
| (87) | Number | WO 2009/150635 |
| Date | 2009-12-17 |
| (30) | Number | Date | Country code |
| 61141 P | 2008-06-13 | US |
| (72) |
SHELTON, David, Louis, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | TREATMENT OF CHRONIC PROSTATITIS |
| TREATMENT OF CHRONIC PROSTATITIS |